You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Emergent Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Emergent
International Patents:73
US Patents:7
Tradenames:2
Ingredients:2
NDAs:3

Drugs and US Patents for Emergent

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emergent Biodefense TEMBEXA brincidofovir TABLET;ORAL 214461-001 Jun 4, 2021 RX Yes Yes 9,371,344 ⤷  Try a Trial Y ⤷  Try a Trial
Emergent Biodefense TEMBEXA brincidofovir TABLET;ORAL 214461-001 Jun 4, 2021 RX Yes Yes 10,487,061 ⤷  Try a Trial Y ⤷  Try a Trial
Emergent NARCAN naloxone hydrochloride SPRAY, METERED;NASAL 208411-002 Jan 24, 2017 DISCN Yes No 9,480,644 ⤷  Try a Trial Y Y ⤷  Try a Trial
Emergent Biodefense TEMBEXA brincidofovir TABLET;ORAL 214461-001 Jun 4, 2021 RX Yes Yes 9,303,051 ⤷  Try a Trial Y Y ⤷  Try a Trial
Emergent Biodefense TEMBEXA brincidofovir SUSPENSION;ORAL 214460-001 Jun 4, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Emergent Biodefense TEMBEXA brincidofovir TABLET;ORAL 214461-001 Jun 4, 2021 RX Yes Yes 8,962,829 ⤷  Try a Trial Y Y ⤷  Try a Trial
Emergent Biodefense TEMBEXA brincidofovir SUSPENSION;ORAL 214460-001 Jun 4, 2021 RX Yes Yes 9,303,051 ⤷  Try a Trial Y Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for EMERGENT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Nasal Spray 4 mg/spray ➤ Subscribe 2016-07-15

Supplementary Protection Certificates for Emergent Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1685839 92292 Luxembourg ⤷  Try a Trial PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.